Table 2.
Thiols (µmol/g) | |||||
Thiols (µmol/g) | — | ||||
IMA/ALB (g/L) | |||||
IMA/ALB (g/L) | 0.186 | — | |||
Fluo-AGE (AU) | |||||
Fluo-AGE (AU) | 0.015 | 0.219∗ | — | ||
AGE (ng/mL) | |||||
AGE (ng/mL) | 0.017 | 0.048 | 0.028 | — | |
GA (mg/L) | |||||
GA (mg/L) | 0.183 | 0.302∗∗∗ | 0.036 | 0.399∗∗∗ | — |
Fructosamines (mol/g) | 0.130 | 0.430∗∗∗ | 0.032 | 0.135 | 0.492∗∗∗ |
Glycation parameters: fructosamine, glycated albumin (GA); oxidation parameters: ischemia-modified albumin (IMA), thiols; glycoxidation parameters: advanced glycation end-products (AGE), fluorescent advanced glycation end-products (Fluo-AGE). Total panel includes diabetic and nondiabetic patients (N = 106). Univariate correlation coefficients and significance between different biochemical parameter values compared by peer were calculated according to Pearson's method: ∗p < 0.05, ∗∗∗p < 0.001.